Xiangwei Lv

1.1k total citations
30 papers, 824 citations indexed

About

Xiangwei Lv is a scholar working on Molecular Biology, Cancer Research and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xiangwei Lv has authored 30 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xiangwei Lv's work include MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (7 papers). Xiangwei Lv is often cited by papers focused on MicroRNA in disease regulation (9 papers), Cancer-related molecular mechanisms research (9 papers) and Circular RNAs in diseases (7 papers). Xiangwei Lv collaborates with scholars based in China. Xiangwei Lv's co-authors include Qiang Su, Binghui Kong, Qiang Su, Ziliang Ye, Yuhan Sun, Zhenbai Qin, Yang Liu, Tongtong Xu, Pan Lu and Guoqiang Zhong and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and American Journal of Physiology-Heart and Circulatory Physiology.

In The Last Decade

Xiangwei Lv

30 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiangwei Lv China 18 475 374 142 97 86 30 824
Bimei Jiang China 21 770 1.6× 400 1.1× 136 1.0× 84 0.9× 181 2.1× 63 1.3k
Tiantian Liu China 20 599 1.3× 236 0.6× 65 0.5× 44 0.5× 103 1.2× 64 1.1k
Ruilian Ma China 10 437 0.9× 279 0.7× 115 0.8× 21 0.2× 69 0.8× 20 683
Yanan Ji China 19 659 1.4× 164 0.4× 78 0.5× 56 0.6× 136 1.6× 56 1.2k
Jie-Ning Zhu China 20 1.1k 2.4× 822 2.2× 355 2.5× 60 0.6× 61 0.7× 36 1.6k
Xiaoya Zhou China 13 515 1.1× 204 0.5× 42 0.3× 61 0.6× 94 1.1× 22 883
Xiaokun Wang China 15 350 0.7× 146 0.4× 64 0.5× 66 0.7× 273 3.2× 53 878
Seema Dangwal Germany 18 684 1.4× 538 1.4× 172 1.2× 27 0.3× 64 0.7× 27 1.2k

Countries citing papers authored by Xiangwei Lv

Since Specialization
Citations

This map shows the geographic impact of Xiangwei Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangwei Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangwei Lv more than expected).

Fields of papers citing papers by Xiangwei Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangwei Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangwei Lv. The network helps show where Xiangwei Lv may publish in the future.

Co-authorship network of co-authors of Xiangwei Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangwei Lv. A scholar is included among the top collaborators of Xiangwei Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangwei Lv. Xiangwei Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lv, Xiangwei, et al.. (2022). Possible implication of miR-142-3p in coronary microembolization induced myocardial injury via ATXN1L/HDAC3/NOL3 axis. Journal of Molecular Medicine. 100(5). 763–780. 12 indexed citations
3.
Deng, Xin, et al.. (2022). SparNet: A Convolutional Neural Network for EEG Space-Frequency Feature Learning and Depression Discrimination. Frontiers in Neuroinformatics. 16. 914823–914823. 17 indexed citations
4.
Su, Qiang, et al.. (2021). Exosomal LINC00174 derived from vascular endothelial cells attenuates myocardial I/R injury via p53-mediated autophagy and apoptosis. Molecular Therapy — Nucleic Acids. 23. 1304–1322. 45 indexed citations
5.
Lv, Xiangwei, et al.. (2021). 6-Gingerol relieves myocardial ischaemia/reperfusion injury by regulating lncRNA H19/miR-143/ATG7 signaling axis-mediated autophagy. Laboratory Investigation. 101(7). 865–877. 22 indexed citations
6.
Lv, Xiangwei, et al.. (2021). miR-451-3p alleviates myocardial ischemia/reperfusion injury by inhibiting MAP1LC3B-mediated autophagy. Inflammation Research. 70(10-12). 1089–1100. 13 indexed citations
7.
Lv, Xiangwei, et al.. (2021). Overexpression of MiR‐29b‐3p Inhibits Atrial Remodeling in Rats by Targeting PDGF‐B Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 3763529–3763529. 15 indexed citations
8.
Qin, Guo‐Wei, Tongtong Xu, Xiangwei Lv, et al.. (2021). Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis. Evidence-based Complementary and Alternative Medicine. 2021. 1–13. 4 indexed citations
9.
Lv, Xiangwei, et al.. (2020). <p>miR-346 Inhibited Apoptosis Against Myocardial Ischemia-Reperfusion Injury via Targeting Bax in Rats</p>. Drug Design Development and Therapy. Volume 14. 895–905. 21 indexed citations
10.
He, Yan, et al.. (2019). Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients. Journal of Thrombosis and Thrombolysis. 48(2). 270–276. 18 indexed citations
11.
Su, Qiang, Yang Liu, Xiangwei Lv, et al.. (2019). Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy. Journal of Molecular and Cellular Cardiology. 133. 12–25. 104 indexed citations
12.
Su, Qiang & Xiangwei Lv. (2019). Revealing new landscape of cardiovascular disease through circular RNA-miRNA-mRNA axis. Genomics. 112(2). 1680–1685. 89 indexed citations
13.
Su, Qiang, et al.. (2019). LncRNA TUG1 mediates ischemic myocardial injury by targeting miR-132-3p/HDAC3 axis. American Journal of Physiology-Heart and Circulatory Physiology. 318(2). H332–H344. 81 indexed citations
14.
Su, Qiang, Xiangwei Lv, Yuhan Sun, et al.. (2018). Role of high mobility group A1/nuclear factor-kappa B signaling in coronary microembolization-induced myocardial injury. Biomedicine & Pharmacotherapy. 105. 1164–1171. 19 indexed citations
15.
Xu, Tongtong, Guo‐Wei Qin, Wei Jiang, et al.. (2018). 6‐Gingerol Protects Heart by Suppressing Myocardial Ischemia/Reperfusion Induced Inflammation via the PI3K/Akt‐Dependent Mechanism in Rats. Evidence-based Complementary and Alternative Medicine. 2018(1). 6209679–6209679. 32 indexed citations
16.
Lv, Xiangwei, Tongtong Xu, Qi Wu, et al.. (2018). 6‐Gingerol Activates PI3K/Akt and Inhibits Apoptosis to Attenuate Myocardial Ischemia/Reperfusion Injury. Evidence-based Complementary and Alternative Medicine. 2018(1). 9024034–9024034. 31 indexed citations
17.
Lv, Xiangwei, et al.. (2018). Role of TLR4/MyD88/NF-κB signaling pathway in coronary microembolization-induced myocardial injury prevented and treated with nicorandil. Biomedicine & Pharmacotherapy. 106. 776–784. 52 indexed citations
18.
Liu, Zhenzhen, et al.. (2015). Comparison of Methods for the Reconstruction of the Hepatic Artery in Mouse Orthotopic Liver Transplantation. PLoS ONE. 10(7). e0133030–e0133030. 5 indexed citations
19.
Pan, Ning, Xiangwei Lv, Rui Liang, Liming Wang, & Qinlong Liu. (2014). Suppression of Graft Regeneration, Not Ischemia/Reperfusion Injury, Is the Primary Cause of Small-for-Size Syndrome after Partial Liver Transplantation in Mice. PLoS ONE. 9(4). e93636–e93636. 17 indexed citations
20.
Lv, Xiangwei. (2013). Soil Moisture Monitoring with EOS/MODIS VSWI Product in Xilingol. Zhongguo nongye qixiang. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bimei Jiang Breakdown of academic impact, for papers by Tiantian Liu Breakdown of academic impact, for papers by Ruilian Ma Breakdown of academic impact, for papers by Yanan Ji Breakdown of academic impact, for papers by Jie-Ning Zhu Breakdown of academic impact, for papers by Xiaoya Zhou Breakdown of academic impact, for papers by Xiaokun Wang Breakdown of academic impact, for papers by Seema Dangwal
Rankless by CCL
2026